Pharscin Pharma: The company has become the holder of the marketing authorization for the Jian'er Xiaoshi oral liquid medication

Pharscin Pharma announced that it recently received the approval notice for the supplementary application of the Jian'er Xiaoshi Oral Liquid from the National Medical Products Administration. The product has completed the change of the drug marketing authorization holder, and the company has become its drug marketing authorization holder. This drug is a pediatric traditional Chinese medicine that has the effects of strengthening the spleen and benefiting the stomach, regulating qi and aiding digestion. It is suitable for children suffering from symptoms such as poor appetite, abdominal distension, heat in the palms and soles, spontaneous sweating, fatigue, irregular bowel movements, and even anorexia and aversion to food caused by dietary irregularities damaging the spleen and stomach. This change will help enrich the company's product pipeline and expand the retail market, increasing the sales varieties in the pediatric digestive field and promoting the company's sustainable development